Table 3.
Description of the number of procedures performed during the study period to detect cervical cancer
| Variables | Cervical-Vaginal Cytopathology/Microflora | Cervical Vaginal Cytopathology/Microflora-Tracking | ||||||
|---|---|---|---|---|---|---|---|---|
| Total N = 1,789,5261 |
Pre N = 1,230,423 |
During N = 559,103 |
p-value | Total N = 4,873,496 |
Pre N = 3,422,169 |
During N = 1,451,327 |
p-value | |
| Age |
42 (33–52) |
42 (33–52) |
42 (33–52) |
0.2 |
43 (35–52) |
43 (35–52) |
43 (35–52) |
< 0.001 |
| Race | 0.051 | 0.051 | ||||||
| Whte |
426,225 (23.82%) |
298,892 (24.29%) |
127,333 (22.77%) |
2,063,132 (42.33%) |
1,434,759 (41.93%) |
628,373 (43.30%) |
||
| Black |
33,092 (1.85%) |
22,991 (1.87%) |
10,101 (1.81%) |
290,929 (5.97%) |
205,205 (6.00%) |
85,724 (5.91%) |
||
| Brown |
149,822 (8.37%) |
103,855 (8.44%) |
45,967 (8.22%) |
1,282,980 (26.33%) |
887,508 (25.93%) |
395,472 (27.25%) |
||
| Yellow |
46,093 (2.58%) |
32,229 (2.62%) |
13,864 (2.48%) |
874,323 (17.94%) |
631,465 (18.45%) |
242,858 (16.73%) |
||
| Indigenous |
1,083 (0.06%) |
739 (0.06%) |
344 (0.06%) |
23,244 (0.48%) |
16,383 (0.48%) |
6,861 (0.47%) |
||
| Ignored |
1,133,211 (63.32%) |
771,717 (62.72%) |
361,494 (64.66%) |
338,888 (6.95%) |
246,849 (7.21%) |
92,039 (6.34%) |
||
| Region | < 0.001 | < 0.001 | ||||||
| Midwest |
66,408 (3.71%) |
49,689 (4.04%) |
16,719 (2.99%) |
368,065 (7.55%) |
271,112 (7.92%) |
96,953 (6.68%) |
||
| Northeast |
147,702 (8.25%) |
106,214 (8.63%) |
41,488 (7.42%) |
1,479,526 (30.36%) |
1,057,261 (30.89%) |
422,265 (29.10%) |
||
| North |
137,271 (7.67%) |
92,928 (7.55%) |
44,343 (7.93%) |
298,650 (6.13%) |
210,217 (6.14%) |
88,433 (6.09%) |
||
| Southeast |
1,344,514 (75.13%) |
915,403 (74.40%) |
429,111 (76.75%) |
1,606,613 (32.97%) |
1,099,955 (32.14%) |
506,658 (34.91%) |
||
| South |
93,631 (5.23%) |
66,189 (5.38%) |
27,442 (4.91%) |
1,120,642 (22.99%) |
783,624 (22.90%) |
337,018 (23.22%) |
||